Welcome to the future of Medicine
3V Medical Research Group has developed a product Luxsol™ Suspension Solution, as a targeted therapeutic therapy to treat Covid-19 and Influenza.
The COVID-19 Pandemic has dominated our lives. Pandemic’s that desperately need treatments. 3V Medical Research Group is committed to treat COVID-19 for everyone without undesirable side effects. There are 25% of the USA population not willing to receive the vaccine at the risk of being infected with COVID-19 virus.
Our Mission
Patents and Trademarks
3V Medical Research Group, Inc. has 55 US and Worldwide patents approved or pending. 9 registered 4 pending US and Worldwide trademarks.